![](/img/cover-not-exists.png)
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Bond, M, Rogers, G, Peters, J, Anderson, R, Hoyle, M, Miners, A, Moxham, T, Davis, S, Thokala, P, Wailoo, A, Jeffreys, M, Hyde, CVolume:
16
Language:
english
Journal:
Health Technology Assessment
DOI:
10.3310/hta16210
Date:
April, 2012
File:
PDF, 359 KB
english, 2012